Aemetis (NASDAQ:AMTX) Rating Increased to Sell at StockNews.com

StockNews.com upgraded shares of Aemetis (NASDAQ:AMTX) to a sell rating in a research note published on Monday morning.

Separately, HC Wainwright reiterated a “buy” rating and issued a $28.00 price objective on shares of Aemetis in a report on Monday, December 23rd. One analyst has rated the stock with a sell rating, one has assigned a hold rating and four have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $12.95.

Aemetis Price Performance

NASDAQ:AMTX opened at $2.20 on Monday. The company has a market capitalization of $109.43 million, a price-to-earnings ratio of -0.97 and a beta of 1.47. The business has a 50 day moving average of $3.06 and a 200 day moving average of $2.92. Aemetis has a 1-year low of $2.04 and a 1-year high of $7.03.

Aemetis (NASDAQ:AMTX) last announced its quarterly earnings data on Tuesday, November 12th. The specialty chemicals company reported ($0.38) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.47) by $0.09. The business had revenue of $81.44 million during the quarter, compared to the consensus estimate of $77.79 million. During the same quarter in the previous year, the firm posted ($0.59) earnings per share. As a group, sell-side analysts anticipate that Aemetis will post -2.07 EPS for the current year.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of AMTX. State Street Corp grew its position in shares of Aemetis by 36.1% in the 3rd quarter. State Street Corp now owns 699,089 shares of the specialty chemicals company’s stock worth $1,608,000 after buying an additional 185,304 shares during the last quarter. Susquehanna Fundamental Investments LLC increased its position in Aemetis by 287.4% during the 2nd quarter. Susquehanna Fundamental Investments LLC now owns 126,078 shares of the specialty chemicals company’s stock valued at $379,000 after purchasing an additional 93,536 shares during the period. Wellington Management Group LLP bought a new position in Aemetis in the 3rd quarter worth $177,000. Geode Capital Management LLC lifted its position in shares of Aemetis by 7.7% in the 3rd quarter. Geode Capital Management LLC now owns 924,293 shares of the specialty chemicals company’s stock worth $2,126,000 after purchasing an additional 66,031 shares during the period. Finally, Rhumbline Advisers boosted its stake in shares of Aemetis by 2,837.1% during the 2nd quarter. Rhumbline Advisers now owns 52,309 shares of the specialty chemicals company’s stock valued at $157,000 after purchasing an additional 50,528 shares in the last quarter. Hedge funds and other institutional investors own 27.02% of the company’s stock.

Aemetis Company Profile

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.